United States· US:68071-2113_1d749c51-f082-f9d5-e063-6394a90a4d8f
ISENTRESS
A raltegravir product containing raltegravir potassium, registered in United States by NuCare Pharmaceuticals,Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Raltegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AJ01 (raltegravir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Raltegravir · ATC J05AJ01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of raltegravir costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Raltegravir · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$18.61
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- RALTEGRAVIR POTASSIUM
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Country
- United States (US)
- ATC code
- J05AJ01
- ATC class
- Raltegravir
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 2
- ndc1168071-2113-6
- ndc1168071211366 TABLET, FILM COATED in 1 BOTTLE (68071-2113-6)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for raltegravir.
Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Raltegravir · interactions on record
55 records
- 15 severe
- 22 moderate
- 18 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Calcium carbonateA02AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Raltegravir in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsIsentress 400 mg filmomhulde tabletMerck Sharp & Dohme B.V.
- SpainISENTRESS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Sharp & Dohme B.V.
- FinlandISENTRESSAbacus Medicine A/S
- CzechiaISENTRESSMerck Sharp & Dohme B.V., Haarlem
- NorwayIsentressMerck Sharp & Dohme B.V. (1)
- PolandIsentressMerck Sharp & Dohme B.V.
- SwedenISENTRESS 400 mg Filmdragerad tablettMerck Sharp & Dohme BV
- IrelandIsentress 400 mg Film-coated tabletMerck Sharp & Dohme BV,
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Bulgaria · Raltegravir Viatris, Ралтегравир Зентива
- Cyprus · Raltegravir Viatris
- Germany · Raltegravir Axiromed, Raltegravir Beta
- Denmark · Raltegravir Viatris, Raltegravir Zentiva
- Estonia · Raltegravir Viatris, Raltegravir Zentiva
- Spain · Raltegravir Dr. Reddys, Raltegravir Zentiva
- Finland · Raltegravir Viatris, Raltegravir Zentiva
- France · Raltegravir Biogaran, Raltégravir Biogaran
- United Kingdom (Northern Ireland) · Raltegravir Amarox, Raltegravir Dr. Reddy's Laboratories (Uk)
- Greece · Ralpecin, Raltegravir Viatris
- Croatia · Raltegravir Viatris
- Iceland · Isentress, Raltegravir Zentiva
- Italy · Raltegravir Dr. Reddy’s, Raltegravir Mylan
- Liechtenstein · Isentress
- Lithuania · Raltegravir Zentiva
- Latvia · Raltegravir Viatris, Raltegravir Zentiva
- Malta · Raltegravir Viatris
- Netherlands · Raltegravir Rockmed Pharma, Raltegravir Viatris
- Norway · Isentress, Raltegravir Viatris
- Poland · Raltegravir Viatris
- Portugal · Raltegravir Mylan, Raltegravir Zentiva
- Romania · Raltegravir Viatris, Raltegravir Zentiva
- Sweden · Raltegravir Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfe9f971-6f6a-4594-a8de-3d1ade3fe6e1 GET /v1/drugs/dfe9f971-6f6a-4594-a8de-3d1ade3fe6e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "400",
"substance": "RALTEGRAVIR POTASSIUM",
"productndc": "68071-2113",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA022145",
"marketing_category": "NDA"
}See everything about raltegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.